Impaired stimulation of 25-hydroxyvitamin D-24-hydroxylase in fibroblasts from a patient with vitamin D-dependent rickets, type II. A form of receptor-positive resistance to 1,25-dihydroxyvitamin D3.
- 1 October 1983
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 72 (4) , 1190-1199
- https://doi.org/10.1172/jci111074
Abstract
We describe studies of the molecular defect in 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] action in cultured skin fibroblasts from a patient previously reported to have vitamin D-dependent rickets, type II. Binding of [3H]1,25-(OH)2D3 in fibroblast cytosol was normal with a Bmax (amount of high affinity binding) of 26 fmol/mg protein and a half-maximal saturation of 0.2 nM. Nuclear binding of [3H]1,25-(OH)2D3 following whole cell uptake was 1.5 fmol/micrograms DNA in patient fibroblasts compared with a range of 0.5-2.9 fmol/micrograms DNA in five control strains. The size of the [3H]1,25-(OH)2D3-receptor complex on sucrose density gradients, 3.8 S, was the same as in normal cells. This patient, therefore, appeared to have a receptor-positive form of resistance to 1,25-(OH)2D3. To document resistance to 1,25-(OH)2D3 in the fibroblasts we developed a method for detection of 1,25-(OH)2D3 action in normal skin fibroblasts. Following treatment of normal cell monolayers with 1,25-(OH)2D3 there was more than a 20-fold increase of 25-hydroxy-vitamin D-24-hydroxylase (24-hydroxylase) activity. Treatment of 10 control cell strains with 1,25-(OH)2D3 for 8 h increased the formation of 24,25-dihydroxy-vitamin D3 from 25-hydroxyvitamin D3 in cell sonicates from less than 0.02 to 0.11-0.27 pmol/min per mg protein. When cells from the patient with vitamin D-dependent rickets, type II were treated with 1,25-(OH)2D3 in a similar manner, maximal 24-hydroxylase activity was only 0.02 pmol/min per mg protein, less than a fifth the lower limit of normal. 24-Hydroxylase activity in fibroblasts from the parents of the patient increased normally following treatment with 1,25-(OH)2D3. We conclude that impaired induction of 24-hydroxylase in the presence of normal receptor binding is evidence for postreceptor resistance to the action of 1,25-(OH)2D3.This publication has 39 references indexed in Scilit:
- Vitamin D: Two Dihydroxylated Metabolites Are Required for Normal Chicken Egg HatchabilityScience, 1978
- Vitamin-D-Dependent Rickets Type IINew England Journal of Medicine, 1978
- Response of Chick Parathyroid Glands to the Vitamin D Metabolites, 1,25-Dihydroxycholecalciferol and 24,25-DihydroxycholecalciferolJournal of Nutrition, 1977
- Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell linesCell, 1977
- Metabolism of 25-hydroxy-vitamin D3 by primary cultures of chick kidney cellsBiochemical and Biophysical Research Communications, 1977
- Dihydrotestosterone binding by cultured human fibroblasts. Comparison of cells from control subjects and from patients with hereditary male pseudohermaphroditism due to androgen resistance.Journal of Clinical Investigation, 1976
- Androgen insensitivity in man: evidence for genetic heterogeneity.Proceedings of the National Academy of Sciences, 1976
- The role of 1,25-dihydroxyvitamin D3 and parathyroid hormone in the regulation of chick renal 25-hydroxyvitamin D3-24-hydroxylaseArchives of Biochemistry and Biophysics, 1975
- Stimulation of 24,25-Dihydroxyvitamin D 3 Production by 1,25-Dihydroxyvitamin D 3Science, 1974
- Characterization of the metabolites of vitamin D3 in the chickSteroids, 1972